Cargando…
Pulmonary sclerosing pneumocytoma and mortality risk
BACKGROUND: Surgical resection is usually recommended for the treatment of pulmonary sclerosing pneumocytoma (PSP). However, no comparative study has demonstrated that surgical resection leads to improved outcomes. We aimed to compare all-cause mortality between patients with PSP who underwent surge...
Autores principales: | Kim, So Jeong, Kang, Hye-Rin, Lee, Choon Geun, Choi, Seung Ho, Kim, Yeon Wook, Lee, Hyun Woo, Lee, Chang-Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641959/ https://www.ncbi.nlm.nih.gov/pubmed/36344955 http://dx.doi.org/10.1186/s12890-022-02199-1 |
Ejemplares similares
-
Pulmonary sclerosing pneumocytoma demonstrating intratumoral hematoma
por: Lee, Ko, et al.
Publicado: (2019) -
Large pulmonary sclerosing pneumocytoma in a young female: A rare lung tumor
por: Kang, Do Kyun, et al.
Publicado: (2021) -
Pulmonary sclerosing pneumocytoma: clinical features and prognosis
por: Zheng, Quan, et al.
Publicado: (2022) -
Pulmonary Sclerosing Pneumocytomas Mimicking Lung Cancer
por: Lizarraga Madrigal, Daniella, et al.
Publicado: (2023) -
Pulmonary sclerosing pneumocytoma mimicking lung cancer: Case report and review of the literature
por: Lim, Jung‐Hwan, et al.
Publicado: (2016)